DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

JP Morgan Upgrades United Therapeutics to Overweight, Raises Price Target to $120

JP Morgan analyst Jessica Fye upgrades United Therapeutics (NASDAQ:UTHR) from Neutral to Overweight and raises the price target from $116 to $120.

Benzinga · 01/31/2020 11:56

JP Morgan analyst Jessica Fye upgrades United Therapeutics (NASDAQ:UTHR) from Neutral to Overweight and raises the price target from $116 to $120.